Literature DB >> 21843558

The elusive middle domain of Hsp104 and ClpB: location and function.

Morgan E Desantis1, James Shorter.   

Abstract

Hsp104 in yeast and ClpB in bacteria are homologous, hexameric AAA+ proteins and Hsp100 chaperones, which function in the stress response as ring-translocases that drive protein disaggregation and reactivation. Both Hsp104 and ClpB contain a distinctive coiled-coil middle domain (MD) inserted in the first AAA+ domain, which distinguishes them from other AAA+ proteins and Hsp100 family members. Here, we focus on recent developments concerning the location and function of the MD in these hexameric molecular machines, which remains an outstanding question. While the atomic structure of the hexameric assembly of Hsp104 and ClpB remains uncertain, recent advances have illuminated that the MD is critical for the intrinsic disaggregase activity of the hexamer and mediates key functional interactions with the Hsp70 chaperone system (Hsp70 and Hsp40) that empower protein disaggregation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843558      PMCID: PMC3219823          DOI: 10.1016/j.bbamcr.2011.07.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  135 in total

1.  ATP binding to nucleotide binding domain (NBD)1 of the ClpB chaperone induces motion of the long coiled-coil, stabilizes the hexamer, and activates NBD2.

Authors:  Yo-Hei Watanabe; Misa Takano; Masasuke Yoshida
Journal:  J Biol Chem       Date:  2005-04-04       Impact factor: 5.157

2.  Structure of the cross-beta spine of amyloid-like fibrils.

Authors:  Rebecca Nelson; Michael R Sawaya; Melinda Balbirnie; Anders Ø Madsen; Christian Riekel; Robert Grothe; David Eisenberg
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 3.  HSP100/Clp proteins: a common mechanism explains diverse functions.

Authors:  E C Schirmer; J R Glover; M A Singer; S Lindquist
Journal:  Trends Biochem Sci       Date:  1996-08       Impact factor: 13.807

4.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+].

Authors:  Y O Chernoff; S L Lindquist; B Ono; S G Inge-Vechtomov; S W Liebman
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

5.  Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model.

Authors:  Kavita C Gokhale; Gary P Newnam; Michael Y Sherman; Yury O Chernoff
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

6.  Heat-shock protein 104 expression is sufficient for thermotolerance in yeast.

Authors:  S Lindquist; G Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.

Authors:  Christophe Lo Bianco; James Shorter; Etienne Régulier; Hilal Lashuel; Takeshi Iwatsubo; Susan Lindquist; Patrick Aebischer
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 8.  Prion proteostasis: Hsp104 meets its supporting cast.

Authors:  Elizabeth A Sweeny; James Shorter
Journal:  Prion       Date:  2008-10-22       Impact factor: 3.931

9.  Heat-shock proteins Hsp104 and Hsp70 reactivate mRNA splicing after heat inactivation.

Authors:  J L Vogel; D A Parsell; S Lindquist
Journal:  Curr Biol       Date:  1995-03-01       Impact factor: 10.834

10.  An Arabidopsis heat shock protein complements a thermotolerance defect in yeast.

Authors:  E C Schirmer; S Lindquist; E Vierling
Journal:  Plant Cell       Date:  1994-12       Impact factor: 11.277

View more
  44 in total

1.  Mechanistic Insights into Hsp104 Potentiation.

Authors:  Mariana P Torrente; Edward Chuang; Megan M Noll; Meredith E Jackrel; Michelle S Go; James Shorter
Journal:  J Biol Chem       Date:  2016-01-08       Impact factor: 5.157

Review 2.  Protein rescue from aggregates by powerful molecular chaperone machines.

Authors:  Shannon M Doyle; Olivier Genest; Sue Wickner
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10       Impact factor: 94.444

3.  Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain.

Authors:  Amber Tariq; JiaBei Lin; Megan M Noll; Mariana P Torrente; Korrie L Mack; Oscar Hernandez Murillo; Meredith E Jackrel; James Shorter
Journal:  FEMS Yeast Res       Date:  2018-08-01       Impact factor: 2.796

Review 4.  The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.

Authors:  Oliver D King; Aaron D Gitler; James Shorter
Journal:  Brain Res       Date:  2012-01-21       Impact factor: 3.252

5.  Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting.

Authors:  Elizabeth A Sweeny; Amber Tariq; Esin Gurpinar; Michelle S Go; Matthew A Sochor; Zhong-Yuan Kan; Leland Mayne; S Walter Englander; James Shorter
Journal:  J Biol Chem       Date:  2019-12-27       Impact factor: 5.157

6.  Therapeutic genetic variation revealed in diverse Hsp104 homologs.

Authors:  Katelyn Sweeney; Hanna Kim; Xiaohui Yan; Zachary M March; Laura M Castellano; Meredith E Jackrel; JiaBei Lin; Edward Chuang; Edward Gomes; Corey W Willicott; Karolina Michalska; Robert P Jedrzejczak; Andrzej Joachimiak; Kim A Caldwell; Guy A Caldwell; Ophir Shalem; James Shorter
Journal:  Elife       Date:  2020-12-15       Impact factor: 8.140

7.  Hsp110 mitigates α-synuclein pathology in vivo.

Authors:  Yumiko V Taguchi; Erica L Gorenberg; Maria Nagy; Drake Thrasher; Wayne A Fenton; Laura Volpicelli-Daley; Arthur L Horwich; Sreeganga S Chandra
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-04       Impact factor: 11.205

8.  Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.

Authors:  Meredith E Jackrel; Morgan E DeSantis; Bryan A Martinez; Laura M Castellano; Rachel M Stewart; Kim A Caldwell; Guy A Caldwell; James Shorter
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

9.  Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.

Authors:  Laura M Castellano; Stephen M Bart; Veronica M Holmes; Drew Weissman; James Shorter
Journal:  Chem Biol       Date:  2015-08-06

10.  The molecular mechanism of Hsp100 chaperone inhibition by the prion curing agent guanidinium chloride.

Authors:  Cathleen Zeymer; Nicolas D Werbeck; Ilme Schlichting; Jochen Reinstein
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.